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Amphipathic polymer pullulan acetate (PA)-coated magnetic nanoparticles were prepared and characterized 
by various physicochemical means. The cytotoxicity and cellular uptake of the magnetic nanoparticles were 
examined. The hyperthermic effect of the magnetic nanoparticles on tumor cells was evaluated. Transmission 
electron microscopy (TEM) showed that the PA coated magnetic nanoparticles (PAMNs) had spherical 
morphology. Dynamic light scattering (DLS) showed that the size distribution of PAMNs was unimodal,with 
an average diameter of 25.8 nm ± 6.1 nm. The presence of the adsorbed layer of PA on the magnetite surface 
was confirmed by Fourier transform infrared (FTIR) spectroscopy. Magnetic measurements revealed that the 
saturation magnetization of the PAMNs reached 51.9 emu/g and the nanoparticles were superparamagnetic. 
Thermogravimetric analysis (TGA) showed that the Fe3O4 particles constituted 75 wt% of the PAMNs. The 
PAMNs had good heating properties in an alternating magnetic field. Cytotoxicity assay showed that PAMNs 
exhibited no significant cytotoxicity against L929 cells. TEM results showed that a large number of PAMNs were 
internalized into KB cells. PAMNs have good hyperthermia effect on KB cells in vitro by magnetic field induced 
hyperthermia. These novel magnetic nanoparticles have great potential as magnetic hyperthermia mediators. 
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Magnetic nanoparticles with tailored surface chemistry 
have recently attracted a great deal of attention by 
virtue of their potential biomedical applications 
including magnetic resonance imaging (MRI) contrast 
enhancement [1–4], hyperthermia [5–7], immunoassay 
[8], and drug delivery [9]. Hyperthermia involves 
applying an alternating magnetic field of suitable 
frequency that produces heat dissipation through the 
oscillation of the internal magnetic moment of 
superparamagnetic particles. Hyperthermia using 
magnetic nanoparticles either alone, or in association 
with classical chemo- or radiotherapies, has been 
recognized as a useful therapeutic modality in the 
treatment of malignant tumors [10, 11] because the 
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neoplastic cells are more thermosensitive than normal 
cells [12]. For hyperthermic applications, nano- 
magnetic particles should have high magnetization 
values in order to generate high thermal energies and 
size smaller than 50 nm with a narrow particle size 
distribution. In addition, hyperthermic thermoseeds 
require a surface coating of the core magnetic particles, 
which has to be not only nontoxic and biocompatible 
but also gives targetable particles with particle 
localization in a specific area. Because of their 
hydrophobic surfaces and large surface area to 
volume ratio, in vivo use of nano-magnetic particles 
trends to result in agglomeration and very rapid 
clearance from the circulation. In addition, a common 
problem of uncoated magnetic nanoparticles is their 
chemical instability with respect to oxidation in air 
[13]. In the case of iron oxides, the final compositions 
are very often intermediate between magnetite  
(Fe3O4) and maghemite (γ-Fe2O3), due to oxidation of 
the particles during the synthesis [14]. Surface 
modification or coating of iron oxide nanoparticles 
with biocompatible polymers is often indispensable 
for in vivo biomedical applications in addition to  
prevent oxidation of the particles. 
Pullulan is a flexible water soluble, neutral linear 
polysaccharide consisting of α-1,6 linked maltotriose 
residues (Fig. 1(a)) which is used extensively as a 
food additive, and has therefore been shown to be 
safe for human use. However, recently pullulan has 
also been investigated for its biomedical applications 
in areas such as targeted drug and gene delivery and 
diagnostic imaging using quantum dots [15, 16], for 
the following reasons: (1) it is non-toxic, (2) its use- 
fulness as a plasma expander, (3) its non-immunogenic 
properties, and (4) its non-antigenic properties. The 
pullulan modified magnetic nanoparticles reported 
previously in the literature were prepared by adding 
an aqueous solution of pullulan to magnetite particles 
dispersed in deoxygenated water [17]. In this method, 
the individual polymeric chains of pullulan need be 
cross-linked with glutaraldehyde. Pullulan modified 
magnetic nanoparticles can afford reduced cytotoxicity 
and enhanced cellular uptake [17]. However, the 
remaining glutaraldehyde may have an adverse effect 
on the human body. In this study, we describe a 
novel method to coat magnetic nanoparticles with 
pullulan acetate (PA) (Fig. 1(b)), a amphipathic 
derivative of pullulan. This method does not require 
 
Figure 1 Chemical structure of pullulan (a) and PA (b) 
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a cross-linking agent, and moreover is a rapid and 
easy process with a variety of ways to control the  
particle size. 
The properties of the PA-coated magnetic nano- 
particles (PAMNs), such as their morphology, particle 
size, and distribution, composition and magnetic 
properties were investigated by transmission electron 
microscopy (TEM), dynamic light scattering (DLS), 
thermogravimetric analysis (TGA), and vibrating 
sample magnetometry (VSM). Heating in vitro in an 
alternating magnetic field was carried out. The 
presence of the coating of PA on the magnetic 
nanoparticles was confirmed by Fourier transform 
infrared spectroscopy (FTIR). In vitro cytotoxicity of 
PAMNs was evaluated using L929 cells as model 
cells. Cellular uptake of nanoparticles, using KB cells 
as model cells, was visualized by TEM. The in vitro 
hyperthermic effect of PAMNs was examined using 
KB cells as model tumor cells. These results obtained 
will be useful for further application of the novel 
magnetic material in tumor thermotherapy. 
1. Experimental 
1.1 Materials 
Pullulan (Mw = 200 000) was purchased from Haya- 
shibara (Tokyo, Japan). Ferric chloride hexahydrate 
(FeCl3·6H2O, >99%), ferrous chloride tetrahydrate 
(FeCl2·4H2O), ammonium hydroxide (25 wt% NH3  
in water), oleic acid (90%), polyvinyl alcohol (Mw 
30 000–70 000), and 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) were obtained 
from Sigma. All other reagents and solvents were  
analytical grade. 
1.2 Synthesis of PA and preparation of magnetite 
nanoparticles 
PA was synthesized following a literature method 
[18]. Magnetic Fe3O4 nanoparticles were prepared by 
controlled chemical co-precipitation of Fe2+ and Fe3+ 
(1:2 ratio) by a modification of the literature method 
[19]. In a typical experiment, FeCl3·6H2O (11.6 g) and 
FeCl2·4H2O (4.30 g) were dissolved in 400 mL of 
deionized water under nitrogen gas protection with 
vigorous stirring at 85 °C. Subsequently, about 20 mL 
of 25 wt% ammonia solution was added to the solution 
and stirring was continued for another 20 min to 
allow growth of the nanoparticles. The solution was 
then cooled to room temperature and the resulting 
particles were subjected to magnetic decantation 
followed by repeated washing with distilled water 
and ethanol. A portion of the resulting black precipitate 
was freeze-dried, and the remainder was redispersed 
in water and an excess of oleic acid (4 mL) was added 
dropwise into the suspension. The dark suspension 
was stirred for 1 h at 85 °C under the protection of 
nitrogen gas. The resulting black magnetite gel was 
isolated by magnetic decantation. The magnetite gel 
was washed twice with sonication in acetone to remove 
excess oleic acid before dispersing in biopolymer  
solutions (see below). 
1.3 Preparation of PAMNs 
PAMNs were prepared by a solvent diffusion method. 
50 mg of wet magnetite gel and 100 mg of PA were 
dissolved in separate 5 mL portions of dimethyl 
formamide (DMF). The two portions were mixed by 
vortex. The resulting solution was then added to an 
aqueous solution of 90 mL of poly(vinyl alcohol) 
(PVA) (0.5%, w/w) by means of a syringe positioned 
with the needle directly in the medium, under 
moderate mechanical stirring. The magnetic particles 
were isolated by ultracentrifugation (Hitachi, CF 
16RX) at 15 000 rpm for 20 min at 4 °C and washed 
three times with deionized water. The free PA was 
removed by magnetic separation of the magnetic 
particles which were subsequently freeze-dried for  
characterization. 
1.4 Characterization 
FTIR spectra of pullulan, PA, naked Fe3O4 particles 
and PAMNs were recorded as KBr discs in the range 
4000–400 cm–1 on a Nicolet 560 FTIR spectrometer. The 
average particle size, size distribution, and morphology 
of the magnetic nanoparticles were monitored using 
a Tecnai TF20 TEM. A drop of well-dispersed nano- 
particles suspension was placed onto an amorphous 
carbon-coated 200 mesh copper grid, followed by 
drying the sample at ambient temperature, before it 
was loaded into the microscope. 
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The mean size and size distribution of the naked 
Fe3O4 nanoparticles and PAMNs were measured by 
DLS (Malvern Mastersizer 2000) in phosphate buffered 
saline (PBS) (pH 7.4). 
The content of Fe3O4 in the PAMNs was determined 
by TGA (Q5000 V3.5 Build 252). Samples weighing 
between 5 and 15 mg were heated from 10 to 800 °C 
at a heating rate of 10 °C/min in air. The magneti- 
zation of the nanoparticles was measured by VSM 
(DMA 1600).  
Changes in temperature of the magnetic nano- 
particles in an alternating magnetic field were observed 
using a heating system designed in Tsinghua 
University. The temperature was monitored using a 
copper-constantan thermocouple in an alternating 
magnetic field (frequency: 100 kHz, field intensity:  
130 Gs). 
1.5 In vitro cell experiments 
1.5.1 Cell cultures 
The cells cultivated for in vitro experiments were 
mouse fibroblast cell line, L929 cells, and human 
nasopharyngeal epidermal carcinoma cell line, KB 
cells. Cell obtained from the cell bank of Peking Union 
Medical College. All cell lines were cultured in RPMI 
Medium 1640 (Gibco) supplemented with 10% fetal 
bovine serum (FBS; Gibco), 100 units/mL penicillin, 
and 100 μg/mL streptomycin at 37 °C in a 5% CO2  
and 95% air humidified atmosphere. 
1.5.2 In vitro cytotoxity/viability studies 
To determine cell cytotoxicity/viability, L929 cells 
were seeded into 96-well tissue culture plates at a 
density of 1× 104 cells/well at 37 °C in a 5% CO2 
atmosphere. After 24 h, the medium in the wells was 
replaced with fresh medium containing PAMNs at 
different concentrations (50, 100, and 200 μg/mL). After 
24 h, the medium containing PAMNs was removed 
and the cells were washed three times with PBS to 
eliminate the remaining magnetic nanoparticles. 100 μL 
of fresh culture medium and 20 μL of MTT dye 
solution (5 mg/mL in PBS pH 7.4) were then added to 
each well. After incubation for 4 h at 37 °C the medium 
was removed. Formazan crystals were extracted with 
200 μL of dimethylsulphoxide (DMSO) and the solution 
was vigorously mixed to dissolve the reacted dye. 
After 10 min, the absorbance of each well was read 
on a microplate reader (Bio-Rad 680) at 570 nm. The 
spectrophotometer was calibrated to zero absorbance, 
using culture medium without cells. The relative cell 
viability (%) relative to control wells containing cell 
culture medium without nanoparticles was calculated 
by the formula [A]test/[A]control × 100, where [A]test is  
the absorbance of the test sample and [A]control is the  
absorbance of the control sample. 
1.5.3 TEM of cells exposed to PAMNs 
The KB cells were seeded in a 12-well plate at a 
concentration of 106 cells/mL. Following incubation 
for 24 h, PAMNs were introduced into the culture 
medium with an iron concentration of 0.1 mg/mL. 
After 4 h, the cells were washed three times with PBS, 
followed by careful detachment with a cell scraping 
knife. The cells were then centrifuged and fixed with 
2.5% glutaraldehyde (Sigma) buffered in 0.2 mol/L 
phosphate buffer (PB) for 1 h at 4 °C. The cells were 
then post-fixed in 1% osmium tetroxide for 2 h at 4 °C, 
washed again with PBS, dehydrated in an alcohol 
series, and embedded in Epon. Ultrathin sections of 
70 nm thickness were examined by TEM at 50 kV. 
1.5.4 Hyperthermic therapy by exposure to an 
alternating magnetic field  
KB cells (1× 104 cells/well) were incubated in 96-well 
plates for 24 h. The medium in the wells was replaced 
with the medium containing PAMNs (200 μL). The 
cells were exposed to an alternating magnetic field 
(frequency: 100 kHz, field intensity: 130 Gs) for 20 min. 
The temperature was adjusted to 45 °C or 47 °C 
according to the concentration of PAMNs. Then the 
medium containing PAMNs was removed and the 
cells were washed three times with PBS to eliminate 
the remaining magnetic nanoparticles. 200 μL of fresh 
culture medium was then added to each well. After 
incubation for 24 h at 37 °C, the cell viabilities were 
determined using MTT assay. The therapeutic effica- 
cies were determined by calculating the differences 
between cell viabilities under treated and nontreated 
conditions. 
Nano Res (2010) 3: 23–31 
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1.5.5 Statistical analysis 
The statistical analysis of experimental data utilized 
the student’s t-test and the results are presented as 
mean ± standard deviations (S. D.). Statistical signifi-  
cance was accepted at a level of p < 0.05. 
2. Results and discussion 
2.1 Preparation and characterization of PAMNs 
To produce well-dispersed iron oxide colloidal 
solutions, we firstly prepared magnetic Fe3O4 nano- 
particles modified with oleic acid, and the amphiphilic 
polymer PA was then coated onto the surfaces of the 
magnetic nanoparticles. The parent nanoparticles were 
synthesized by coprecipitation of ferrous and ferric 
ions in aqueous solution by addition of ammonium  
hydroxide. 
Comparison of the FTIR spectra of pullulan (Fig. 2(a)) 
and PA (Fig. 2(b)) confirms the introduction of the 
acetate group in PA (Fig. 2(b)), as indicated by the 
C=O stretch at 1750 cm–1, CH3 deformation at 1370 
cm−1, and O–C=O bend at 602 cm–1. The absorption 
peak at 3470 cm–1 arising from the stretching vibration 
of the hydroxyl group is weaker in the spectrum of 
PA compared to that in pullulan. For the naked Fe3O4 
(Fig. 2(c)), the peak at 577 cm–1 can be attributed to 
the Fe–O groups. Comparing the FTIR spectra of 
naked Fe3O4 (Fig. 2(c)) and that of PAMNs (Fig. 2(d)),  
the characteristic bands of PA appeared near 1750 cm–1 
and 1370 cm–1 in the spectrum of the PAMNs, 
confirming that PA was coated on the surface of the 
nanoparticles. 
The shape, size, and degree of uniformity of the 
naked Fe3O4 nanoparticles and PAMNs were observed 
by means of TEM. The TEM image of the naked 
Fe3O4 nanoparticles (Fig. 3(a)) shows that the naked 
Fe3O4 nanoparticles were cubic shaped with an 
approximate size of around 10 nm and the particles 
were strongly agglomerated. This is similar to other 
reports in the Refs. [13, 20]. The PAMNs were nearly 
spherical in shape and well-separated, but there was 
no significant change in size resulting from the PA  
coating process, as shown in Fig. 3(b).  
 
Figure 2 FTIR spectra of pullulan (a), PA (b), naked Fe3O4 
particles (c), and PAMNs (d) 
 
Figure 3 TEM images of naked Fe3O4 nanoparticles (a) and 
PAMNs (b) 
Figure 4 shows the average size and size distribution 
of the naked Fe3O4 and PAMNs, as obtained by DLS. 
The size distribution of the naked Fe3O4 nanoparticles 
was bimodal, whilst that of PAMNs was unimodal. 
The average particle sizes were 70.8 nm ± 4.4 nm and 
25.8 nm ± 6.1 nm for Fe3O4 nanoparticles and PAMNs, 
respectively. We believe that the bimodal size distri- 
bution of Fe3O4 nanoparticles can be mainly attributed 
to particle aggregation. The average diameters obtained 
by DLS were larger than the sizes determined from 
the TEM images for the corresponding samples. This 
is presumably because DLS gives the mean hydro- 
dynamic diameter of the magnetite core surrounded 
by the organic and solvation layers, whereas TEM 
gives the diameter of magnetic nanoparticles alone in 
the dry state [21–23]. 
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TGA was performed to confirm the coating 
formation and to estimate the content of Fe3O4 in the 
PAMNs. As shown in Fig. 5, the TGA curve shows 
that for the naked Fe3O4 particles the weight loss over 
the temperature range from 10 to 800 °C is about 
2.5 wt%. This might be due to the loss of residual 
water in the sample. In contrast, for the PAMNs a 
significant weight loss was observed above 200 °C. 
This can be attributed to decomposition of the organic 
components of the coating. From the TGA curve, the 
content of the Fe3O4 particles in the PAMNs was 
estimated to be about 75 wt%. This value was used 
below to estimate the net magnetization of the Fe3O4  
particles in the PAMNs. 
The superparamagnetic properties of magnetic 
nanoparticles are critical to ensure their application 
in the biomedical and bioengineering fields, since 
 
Figure 5 Thermogravimetric analysis (TGA) of naked Fe3O4 
particles (a) and PAMNs (b) 
they prevent the particles from aggregating and 
enable them to redisperse rapidly as soon as the 
magnetic field is removed. To study the magnetic 
properties of the surface coated nanoparticles, 
magnetization measurements were performed using 
VSM. The magnetization curves for both the naked 
Fe3O4 nanoparticles and the PAMNs (Fig. 6) showed 
no hysteresis and were completely reversible at 300 K. 
Neither coercivity nor remanence were observed, 
indicating the superparamagnetic nature of both 
materials. The saturation magnetization (MS) of the 
naked Fe3O4 nanoparticles and the PAMNs was 
determined to be 68.8 and 51.9 emu/g, respectively. 
The value for the PAMNs was lower than that of the 
naked nanoparticles due to the presence of the organic 
components. The MS value expected for the PAMNs 
can be estimated on the basis of the TGA data via the 
 
Figure 6 Magnetization curves for naked Fe3O4 particles (a) and 
PAMNs (b) at room temperature 
 
Figure 4 Particle size distributions of naked Fe3O4 particles (a) and PAMNs (b) 




χ= −3 4Fe OS S (1 )M M  
where 3 4Fe OSM  is the saturation magnetization of 
Fe3O4 nanoparticles (68.8 emu/g) and χ  is the weight 
loss (wt%), determined by TGA. The MS value of 
PAMNs calculated via TGA correlates well with that 
determined by VSM. Moreover, the MS value of the 
PAMNs was higher than those for polymer-modified 
magnetites prepared by other methods [23, 24]. The 
higher magnetic content of our PAMNs ensured a 
better response of the nanoparticles towards an external 
magnetic field. 
Figure 7 shows the changes in temperature of 
different concentrations of PAMNs in an alternating 
magnetic field. As the concentration of the magnetic 
particles increased, the temperature rise of the magnetic 
particles increased. The temperature of mixtures 
containing 20 and 40 mg/mL PAMNs in an alternating 
magnetic field reached 56 °C and 85 °C, respectively, 
within 20 min. The temperature change of the 
mixture with 40 mg/mL PAMNs was rapid, with the 
temperature reaching as high as 51 °C within 1 min. 
This rapid temperature change is advantageous for 
applications in hyperthermia. Magnetic particles in 
an alternating magnetic field must reach a temperature 
of 42–46 °C to be effective. As the time to reach    
this temperature gets longer, the normal tissues 
surrounding the tumor tissues sustain more damage 
from the magnetic field. Thus, shorter time periods  
are necessary for the preservation of normal tissues. 
 
Figure 7 Temperature changes for different concentrations of 
PAMNs in an alternating magnetic field 
2.2 Cytotoxicity and cellular uptake of magnetic 
nanoparticles 
The MTT assay for cell viability evaluation has been 
described as a suitable method for detection of 
biomaterial toxicity [25]. MTT is a yellow, water- 
soluble tetrazolium salt. Metabolically active cells are 
able to convert this dye into a water-insoluble dark 
blue formazan by reductive cleavage of the tetrazolium 
ring. The formazan crystals can then be dissolved in 
an organic solvent such as DMSO and quantified by 
measuring the absorbance of the solution at 570 nm; 
the resulting value is related to the number of living 
cells. As shown in Fig. 8, PAMNs showed no cytotoxic 
effects against L929 cells and they remained more  
than 90% viable relative to the control, even at 
concentrations of PAMNs as high as 0.2 mg/mL. There 
was no significant difference between two groups in  
the cells viability. 
Uptake of magnetic nanoparticles by tumor cells is 
essential for intracellular hyperthermia. To confirm 
that the PAMNs were indeed internalized by tumor 
cells and to visualize the location of the nanoparticles 
inside the cells after the internalization, TEM images 
were taken on KB cells that had been cultured with 
PAMNs (Fig. 9(b)) and compared with cells that had 
been cultured in the absence of PAMNs (Fig. 9(a)). 
This comparison shows that a large number of 
PAMNs accumulated in KB cells treated with 
PAMNs and appeared as black dots scattered in the 
cell cytoplasm. Some particles were also apparent on 
the cell surface. At higher magnification, it can be  
 
Figure 8 Cytotoxicity profiles of PAMNs when incubated with 
L929 cell lines, as determined by MTT assay. Percentage viability 
of L929 was expressed relative to control cells (n = 8). Results 
are represented as a mean with bars showing the S. D. 




Figure 9 TEM images of KB cells (a) and KB cells cultured 
with PAMNs (b) 
seen that the particles were located within a vesicle- 
like structure (inset of Fig. 9(b)), which is indicative 
of endocytosis of the particles. 
2.3 Hyperthermic effect of PAMNs on tumor cells 
We next determined the therapeutic potential of 
PAMNs as magnetic hyperthermic mediators with 
KB cells as a model cell by using the MTT assay. As 
shown in Fig. 10, we found that KB cells incubated 
with PAMNs in an alternating magnetic field showed 
therapeutic efficacies of about 56% and 78% at 45 °C 
and 47 °C, respectively. The therapeutic efficacy was 
significantly different (p < 0.01) from that observed  
with a magnetic field alone. 
 
Figure 10 Hyperthermia efficacies of PAMNs on KB cells after 
exposure to an alternating magnetic field (**p﹤0.01 compared 
with magnetic field alone) 
3. Conclusions 
A novel type of PAMNs has been fabricated by a 
solvent diffusion method. The magnetic nanoparticles 
were spherical in morphology with a unimodal size 
distribution. The mean diameter of the particles was 
25.8 nm ± 6.1 nm. The saturated magnetization of the 
composite nanoparticles reached as high as 51.9 emu/g 
and the nanoparticles showed superparamagnetism. 
The magnetic PA-coated nanoparticles have high 
magnetite content and good biocompatibility. The 
composite nanoparticles have good heating 
properties in an alternating magnetic field and have 
evident cellular uptake by tumor cells. The PAMNs 
have an excellent therapeutic efficacy on KB cells 
stemming from the magnetic field induced 
hyperthermia. The new nanoparticles described here 
are very promising nanosystems for hyperthermic  
treatment of tumors.  
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